78
views
0
recommends
+1 Recommend
0 collections
    20
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Economics of Dialysis in India

      other
      Indian Journal of Nephrology
      Medknow Publications

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chronic kidney disease is a worldwide public health problem, a social calamity and an economic catastrophe. In the year 2000, in the United States (US) alone, about 30 million people were diagnosed with chronic kidney disease (CKD). It is estimated that by 2010, six million worldwide would need renal replacement therapy (RRT) costing 28 billion dollar.[1] Burden of CKD in India The exact burden of CKD in India still remains undefined with only limited data from the three population-based studies addressing this issue.[2–4] It is hoped that the CKD registry, recently established by the Indian Society of Nephrology, may provide useful epidemiological data in the future. In the prevention study done in Chennai, the prevalence at the community level is 8600 per million population (pmp) in the study group and 13900 pmp in the control group. The second study based in Delhi[3] revealed a prevalence of CKD (serum creatinine more than 1.8 mg %) at 7852 pmp. The third study from Bhopal revealed an incidence of 151 pmp suffering from end stage renal disease (ESRD). Do we have the resources and skill to handle this ever increasing population of ESRD in India? Economic Scenario in India As per the December 2007 index declared by Rajya Sabha, the per capita income in India is Rs 20734 per annum. The total population is 113 crore of which 26% live below the poverty line (BPL) where the daily earning is Rs 10, in comparison, the international standard BPL is US $1 per day i.e. Rs 45 per day. By this parameter, in India, 70% of the population would be BPL. The government spends barely US $8 per capita on health with priorities more on infectious disease, sanitation, nutrition etc[4] (MK Mani et al.) Facilities for RRT in India In the absence of any available data, Mumbai Kidney Foundation (MKF) conducted a data collection exercise with the help of industry, sources, personal discussion with nephrologists and telephonic confirmation of dialysis centers. India has close to 950 nephrologists (not all ISN members) all over the country. There are 700 dialysis centers with a total of 4000 dialysis machines, predominantly in the private sector and mainly concentrated in cities, especially metros. There are around 20,000 patients undergoing dialysis at these centers [Tables 1 and 2]. There are around 170 government recognized transplant centers in India, performing around 3500 transplants annually. The patients on CAPD number less than 5000. Clearly, the choices and facilities for RRT are predominantly focused on maintenance hemodialysis and are woefully inadequate. Table 1 State of RRT zone wise Zone No of Dialysis centers No. of Dialysis Machines No. of dialysis per month Cost of dialysis per session No. of transplant centers No. of transplant per month North 229 1106 50,560 1250 26 85 South 306 1453 85,440 1100 88 117 East 108 430 27,050 1350 15 25 West 175 1000 90,000 1000 37 71 Table 2 State of RRT city wise City No of Dialysis centers No. of Dialysis Machines No. of dialysis per month Cost of dialysis per session No. of transplant centers No. of transplant per month Delhi 79 490 28,500 1600 10 35 Mumbai 112 600 40,000 750 20 16 Chennai 44 146 10,220 1200 17 34 Calcutta 36 250 20,000 1100 10 20 Cost of RRT in India The MKF data also gave insights into the costing of ESRD management [Table 3]. Table 3 Zone and city wise cost of dialysis in India Zone Cost of dialysis (Rs) per session North 1250 South 1100 East 1350 West 1000 Delhi 1600 Mumbai 750 Chennai 1200 Calcutta 1100 The cost of each hemodialysis (HD) session in India varies from Rs 150 in government hospitals to Rs 2000 in some corporate hospitals. The monthly cost of HD in most private hospitals average Rs 12000 and the yearly cost of dialysis is Rs 1, 40000, equivalent of $3000, which is in sharp contrast to an annual cost of $60,000 in the US and UK. So we are the cheapest in the world and yet more than 90% of Indians cannot afford it. The cost of an AV fistula construction is Rs 6000 to Rs 20000 from a government hospital to varying grades of private hospitals. The average cost of erythropoietin per month is Rs 4000 (bio similar) to Rs 10000 (the pioneer brand). The average cost of kidney transplant varies from Rs 50000 in a government set-up to Rs 300000 in an average private hospital. Also the yearly maintenance cost post transplant for drugs amounts to Rs 12 0000 per year or Rs 10000 per month. Actual Cost Break-up of Dialysis in a Private set up MKF conducted a survey of actual costing of dialysis in few private hospitals in different cities of India [Table 4] and asked for their running cost of maintenance of hemodialysis in centers that have a chronic dialysis program and we came up with interesting findings. Table 4 Actual costing of Dialysis Consumables Rs 350 Electricity Rs 50 Water, telephone, Insurance Rs10 Annual Maintenance - dialysis machine RO plant, premises Rs 20 Repairs & wear & tear Rs 20 Depreciation Rs 100 Honorarium to nephrologist Rs 100-200 Staff Salary Rs 100-200 Total Rs 750-950 # Interest on capital Expenditure - Variable the cost differed from a nephrologist owned facility versus a corporate hospital the administration greatly exaggerated the cost Even in large corporate hospitals the recurrent cost dialysis worked out to be between Rs 700-900 as shown in the Table 4. The average cost to the patient across the country works out to be Rs 1100, which truly is, beyond the reach of more than 90% of India. To increase the reach of dialysis, bring it out of the corporate hospital set up and make it cheaper in the smaller free standing units or nephrologists-owned units. Concept of Nephrologist Owned Unit Is it cost effective? The answer is yes! If you do not mind the travails of running a center. One could either own the set up or take it on lease and pay rent. It could be a day care centre attached to your consulting room, or a full fledged small hospital with indoor facilities. By my own experience, the cost of a single dialysis session to the nephrologist comes to less than 600 if we make bulk purchases. Laboratory facilities or outsourcing can fetch additional income. Sale of EPO after obtaining a pharmacy license is easy and lucrative and can easily subsidize the cost of dialysis. Our Experience in Mumbai If you go through the table, you will realize that Mumbai has the distinction of offering the cheapest dialysis in India at an average cost of Rs 700 per session largely because of the presence of two distinct models which have been in existence since many years [Table 5]. Table 5 Costing of our 700 dialysis done last month in a nephrologist-owned unit Items Monthly Expenses (Rs.) Per dialysis (Rs.) Formalin 1470 2 Hypochloride 630 1 Hydrogen Peroxide 480 0.7 Acitic Acid 1110 1.6 Dialyzers (118 no) 60,000 86 Bicarb Cans (303 can) 45,000 64 Tubing Set (32 sets) 4,160 6 A-V.Fistula Needles (1400) 29,400 42 Normal saline (1 Liter 707 bottles 14,140 20 Ns 500 Ml 350 4,550 6.5 Gloves (Per day 2box × 26 Days) 9,256 13 Heparine (250 Vials Of 25000 Units) 7,000 10 Gauze (40packs) 10,080 14.4 Syringes (20ml 707) 5,567 8 Micropore Sticking Plaster 1,616 2.3 Neosporin Powder 2,418 3.5 IV Set (707 pieces) 5,656 8 Material Total expenses 202533 289 Concept of Free Standing Unit Also called community dialysis centre or satellite dialysis units, they essentially offer only dialysis facility with no admission facility. Thus, they can offer dialysis at a reasonable price by cutting down the overheads. It comprises of a full fledged dialysis centre with 10-20 dialysis machines, isolated machines for Hepatitis B and C, RO plant and a resuscitation trolley with monitor and defibrillator. It also has trained nurses, technicians and doctors trained in resuscitation of a serious patient. The patient is screened at the entry point and taken only if he is stable for OPD dialysis. Semi-acute problems are solved by telephonic consultation between the RMO and nephrologist. During an occasional acute emergency, the RMO or the paramedics resuscitate and if need be transfer to a hospital. The nephrologist reviews the patient at least once in a week, if not daily. Such a concept of free standing unit already exists in the USA and Singapore. Based on this model, presently, Mumbai has 17 such free standing units out of a total of 112 dialysis centers in the city. Concept of Charitable Dialysis Unit The second model, which brought down the cost of dialysis further down in Mumbai, was the involvement of philanthropists and setting up of non-governmental organization (NGO) backed charitable dialysis units, either in an established hospital or as free standing units. The involvement of the NGO can be in the following manner. The entire space and machinery belongs to the trust and they provide dialysis on a no profit no loss basis. The NGO is interested only in donating machines and RO plant to an already existing private dialysis centre and in lieu of the donation gets a fixed number of free dialysis to help poor patients. The philanthropist is interested in donating dialysis machine and wants the unit to be named after him or gets into the advisory board of the dialysis unit. The NGO enters into a public-private partnership with the government which provides space for the unit in a government hospital and the NGO runs the charitable dialysis unit. Other areas in which NGOs or philanthropists work in dialysis field are: Bulk purchase of medicines especially injection Erythropoietin and providing them at an extremely subsidized price to dialysis patients. Bulk purchase of dialyzers, tubings and other disposable items used for dialysis and selling them to patients at subsidized rates. Offering pick up and drop services to dialysis patients. Offering free monthly rations to poor CKD patients. Holding blood donation camps for providing blood to dialysis patients. As a result of promoting these two concepts, Mumbai has 112 dialysis centers, of which 17 are free standing units. Of the 600 dialysis machines which Mumbai has, 150 are in charitable units. In Mumbai, there are about 5000 dialysis patients of which 1250 are taking dialysis at less than Rs 350 per dialysis and the average price of dialysis is Rs 700 - 750 per session, which is the cheapest in the country (National average cost is Rs 1100). Further more, some patients pay less than Rs 100 per dialysis. Suggestions for Increasing the Outreach of Dialysis all over India In summary what can be done to make dialysis more affordable? The Mumbai model can be used as an example to improve the availability as well as affordability of dialysis therapy all over the country. This can be done in the following manner: Build middle level cost effective nephrologist-owned dialysis units costing Rs 800 per session as dialysis cost. Encourage free standing units or satellite dialysis units Involve philanthropists to adopt patients and donate machines. There is no dearth of such people wanting to help for a good cause. Encourage the govt. to lend space for private public partnership in a govt. hospital with NGO participation. Lobby with the govt. to subsidize or make dialysis equipment and disposables tax free. If multiplexes can enjoy tax free holidays, dialysis units also deserve some help from the government. Also, let the electricity used by such units be charged at non-commercial rates. Buy cheap labor by training intelligent, smart, non-graduates to become dialysis technicians, thereby bringing down the labor cost. ISN can start such courses. ISN should back its nephrologists for every medico legal case arising out of there subsidized dialysis units. This can be done by laying minimum standard of care criteria which the units need to adhere to Thus one can be cynical and say there are two options - let patients succumb to their illness as Indians cannot afford RRT or adopt the Mumbai model of providing RRT at highly subsidized rates.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Prevalence of chronic renal failure in adults in Delhi, India.

          Chronic renal failure (CRF) is a debilitating condition responsible for high morbidity and mortality and is a financial burden on government and society. Because of its costs and the complexity of its treatment, proper care is available to very few patients in India. A community-based study has not been done to determine the prevalence of CRF in India. We used a multi-stage cluster sampling method in the South Zones of Delhi. In each area, we first contacted the local social leader and explained the study and the medical information pamphlets. On pre-scheduled days, the study team canvassed the study zone. The individuals contacted responded to a detailed questionnaire, and had a physical examination, a dipstick urine test for albumin and sugar and a blood test for serum creatinine. A serum creatinine >1.8 mg% defined renal failure. A repeat test for serum creatinine was done after 8-12 weeks to confirm chronicity of renal failure. If it was >1.8 mg% after 3 months in the absence of reversible factors, CRF was diagnosed. The person found to have CRF was asked to attend a hospital renal clinic for further investigations and individualized management. A total of 4972 persons were contacted for the study. Their mean age was 42+/-13 years; 56% were males. Out of the 4972 who were initially approached, 4712 agreed to give the blood sample, and thus were included for the evaluation of CRF. CRF was found in 37 of them. Thus, the prevalence of CRF in that adult population was 0.785% or 7852/million. The prevalence of CRF in India makes it a serious problem in need of urgent efforts to contain it.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            USRDS 2005 Annual Data Report; Atlas of End-Stage Renal Disease in the United States

            (2005)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy.

              Chemokine receptor 5 (CCR5) plays an important role in the recruitment of monocytes and T cells in inflammation and experimental studies suggest that CCR5 might be involved in the pathogenesis of IgA nephropathy. A mutation in the CCR5 gene (CCR5 Delta32), leading to a nonfunctional receptor, was recently described. We therefore evaluated the potential role of this mutation on renal survival in patients with IgA nephropathy. The distribution of the CCR5 Delta32 genotype was determined by polymerase chain reaction (PCR) analysis in 228 patients with biopsy-proven IgA nephropathy. In 190 patients with available demographic and clinical follow-up data, the effect of the mutation on the clinical outcome was analyzed using the Log-rank test and the Cox proportional hazard model. In vitro, the influence of the CCR5 Delta32 genotype on the chemotactic response of monocytes was assessed. Of the 190 patients, 158 (83.2%) had a CCR5 wild-type genotype, 29 (15.3%) were heterozygous, and three patients had a homozygous CCR5 Delta32 genotype (1.6%). Renal survival was significantly longer in patients with the CCR5 Delta32 genotype than in the wild-type group (Log-rank P < 0.001). Using the multivariate Cox proportional hazard model, the CCR5 Delta32 genotype was identified as an independent factor associated with a lower risk to develop end-stage renal disease (ESRD) [hazard ratio (HR) 0.23, 95% CI 0.09 to 0.57, P= 0.002]. In vitro analysis of monocytes from CCR5 Delta32 carriers showed a reduced chemotactic response to CCR5 ligands in vitro. Our study demonstrates an independent role of the CCR5 Delta32 genotype for the clinical outcome in IgA nephropathy. In vitro experiments revealed a reduced chemotactic response of monocytes from CCR5 Delta32 carriers, thus pointing out a possible pathophysiologic explanation for the beneficial effect of the CCR5 Delta32 genotype.
                Bookmark

                Author and article information

                Journal
                Indian J Nephrol
                IJN
                Indian Journal of Nephrology
                Medknow Publications (India )
                0971-4065
                1998-3662
                January 2009
                : 19
                : 1
                : 1-4
                Affiliations
                Mumbai Kidney Foundation, Mumbai, India
                Author notes
                Address for correspondence: Dr. Umesh Khanna, Mumbai Kidney Foundation, 501, Pooja Residency, Derasar Lane, Ram Nagar, Borivli (W), Mumbai - 400092, India. E-mail: mu_khanna@ 123456yahoo.co.in
                Article
                IJN-19-1
                10.4103/0971-4065.50671
                2845186
                20352002
                4f776405-4b49-4b2b-8813-61e365d2dfc7
                © Indian Journal of Nephrology

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Categories
                Perspective

                Nephrology
                Nephrology

                Comments

                Comment on this article